Glycyrrhizin reduces cerebral infarction volume and attenuates CI/RI by lowering MDA levels, decreasing the number of positive apoptotic cells, and up‐regulating SOD, catalase, and GSH‐PX activities, indicating that glycyrrhizin may be a potential anti‐ischemic drug [112]. This evidence concerns the gene CAT and brain infarction.